{"Title": "Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?", "Year": 2020, "Source": "J. Nucl. Cardiol.", "Volume": null, "Issue": null, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 0, "DOI": "10.1007/s12350-020-02275-1", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088165695&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85088165695", "SubjectAreas": [["Radiology, Nuclear Medicine and Imaging", "MEDI", "2741"], ["Cardiology and Cardiovascular Medicine", "MEDI", "2705"]], "AuthorData": {"20736050000": {"Name": "Wechalekar K.", "AuthorID": "20736050000", "AffiliationID": "60009009", "AffiliationName": "Department of Nuclear Medicine, Royal Brompton Hospital"}, "6506002568": {"Name": "Wechalekar A.D.", "AuthorID": "6506002568", "AffiliationID": "60022148", "AffiliationName": "National Amyloidosis Centre, University College London"}}}